Timing matters more than almost anything
The benefit-to-risk balance is most favourable for healthy women under 60 or within about ten years of their final period. Starting much later shifts that calculation.
Hormone Replacement Therapy
What HRT actually is — and what the evidence says in 2026
Hormone therapy is the most studied and most misunderstood treatment in women's health. This guide explains what it is, how bioidentical therapy differs, which hormones are involved, what the benefits and risks really are, and what the research found once the headlines moved on.
Education first. Nothing on this page is a recommendation — it's the background you'd want before a conversation with a clinician.
The basics
HRT, MHT, BHRT — what the terms mean
Hormone replacement therapy (HRT) — increasingly called menopausal hormone therapy — replaces the hormones the ovaries stop producing. In practice that means estrogen, progesterone for anyone with a uterus, and sometimes testosterone.
Bioidentical hormone replacement therapy (BHRT) describes hormones whose molecular structure matches the ones the body makes. Estradiol and micronized progesterone are bioidentical and FDA-approved. Compounded bioidentical preparations go a step further, allowing a pharmacy to prepare a specific strength and base rather than working from a handful of fixed tablet sizes.
The distinction that matters clinically is usually not the marketing word but three practical variables: which hormone, at what dose, delivered how. Oral estrogen and transdermal estradiol behave differently in the body. A synthetic progestin and micronized progesterone are not interchangeable.
A common confusion
Bioidentical does not mean unregulated
Plenty of bioidentical hormones are conventional, FDA-approved prescriptions. What varies is whether a preparation is manufactured at a fixed strength or compounded to order. Both are prescription medicines. Both require a clinician, a history and follow-up.
The hormones involved
Four hormones do most of the work
Hormone therapy is rarely about one molecule. Each hormone below has its own guide explaining what it does, what low and high look like, and how it interacts with the others.
Estrogen
Regulates temperature, sleep architecture, skin and vaginal tissue, blood vessels and bone turnover. Its decline drives the symptoms most people picture when they hear 'menopause'.
Learn About EstrogenProgesterone
Calms the nervous system and protects the uterine lining. In anyone with a uterus taking estrogen, progesterone is not optional — it is what keeps the endometrium safe.
Learn About ProgesteroneTestosterone
A women's hormone too. It contributes to libido, motivation, muscle mass and energy, and it falls gradually from the late twenties onward rather than all at once.
Learn About TestosteroneDHEA
An adrenal precursor the body converts into testosterone and estrogens in peripheral tissue — increasingly relevant after the ovaries stop being the main source.
Learn About DHEAThyroid hormone and cortisol aren't replaced by HRT, but they shape how it feels. Both are usually evaluated at the same time — see thyroid and cortisol.
Why hormones change
Hormone decline has a timeline
Knowing which stage you're in changes what your symptoms mean — and whether hormone therapy is even the right conversation yet.
Typically 35–45
Perimenopause
Ovulation becomes inconsistent, progesterone falls first, and estradiol swings high then low. Cycles can still look regular while symptoms are already disruptive.
Read About Perimenopause12 months without a period
Menopause
Estradiol, progesterone and testosterone settle at a fraction of their former levels, and what used to feel cyclical becomes constant.
Read About MenopauseThe decades after
Postmenopause
Symptoms may soften, but the long-term effects of low estrogen on bone, the vagina and urinary tract, and cardiometabolic health continue.
Read About PostmenopauseOften overlooked
Accelerating factors
Surgical or medical menopause, chronic stress, thyroid disease and certain medications can pull hormones down earlier and faster than age alone would.
Read About Accelerating factorsPerimenopause can start a decade before your last period — which is why so many women are told their labs are normal while they feel anything but.
Benefits
What hormone therapy is good at
Effects are strongest where estrogen receptors are densest: the brain's temperature centre, the vaginal and urinary tissues, and bone.
Vasomotor symptoms
Hormone therapy remains the most effective treatment available for hot flashes and night sweats, which is the consensus position of every major menopause society.
Sleep and mood
When night sweats and 3am waking ease, sleep consolidates. Many women report steadier mood as a downstream effect rather than a separate one.
Genitourinary symptoms
Vaginal dryness, discomfort with intimacy and recurrent urinary symptoms respond well to estrogen — often to a low-dose local preparation alone.
Bone protection
Estrogen slows the bone loss that accelerates sharply in the first years after menopause, and is approved for the prevention of postmenopausal osteoporosis.
Body composition and energy
Restoring estradiol and, where appropriate, testosterone can make it easier to hold muscle and respond to training. Hormone therapy is not a weight-loss treatment.
Long-term health signals
In women who start therapy near menopause, observational and trial data suggest a more favourable cardiovascular and all-cause mortality picture than in those who start much later.
Risks and considerations
The honest version of the risk conversation
Hormone therapy is not risk-free, and it isn't right for everyone. The variables below do most of the work in deciding where an individual lands.
Route of delivery changes the risk profile
Transdermal estradiol — creams, gels, patches — is not associated with the increase in venous clot risk seen with oral estrogen, because it bypasses first-pass liver metabolism.
Breast cancer risk is small and depends on the regimen
The increase seen with combined estrogen-plus-progestin therapy in the Women's Health Initiative was under one additional case per thousand women per year, and estrogen-only therapy in that trial did not show an increase.
Some histories are contraindications
A personal history of breast cancer, unexplained vaginal bleeding, active liver disease, or a prior stroke or clotting event all change what is appropriate. This is a clinical decision, never a questionnaire.
Progesterone is non-negotiable with a uterus
Unopposed estrogen increases the risk of endometrial hyperplasia and cancer. Anyone with a uterus taking systemic estrogen needs adequate progesterone alongside it.
Compounded is not the same as unmonitored
Compounded bioidentical preparations allow precise dosing, but they carry the same physiology and the same monitoring requirements as any other hormone therapy.
Important
This page is education, not medical advice
Nothing here can tell you whether hormone therapy is appropriate for your body. That requires a full history, an examination of your risks, and — in most cases — lab work, reviewed by a licensed clinician.
The research
How the science actually changed
Most of the fear women carry about hormone therapy traces to a single trial reported in 2002. Here is what happened next.
2002
The Women's Health Initiative
The WHI's early reporting caused a global collapse in hormone therapy use. The average participant was 63 — more than a decade past menopause — and the trial used oral conjugated equine estrogen with a synthetic progestin, not transdermal estradiol with progesterone.
2007–2016
The timing hypothesis
Re-analyses of the WHI, along with the ELITE and KEEPS trials, converged on the same theme: age at initiation and years since menopause substantially change the observed outcomes, particularly for cardiovascular measures.
2017
18-year WHI follow-up
Extended follow-up published in JAMA found no increase in all-cause, cardiovascular or cancer mortality with either regimen over 18 years — a materially different headline from the one most women remember.
2022–present
Current society guidance
The Menopause Society, ACOG and the Endocrine Society all now state that for symptomatic women under 60 or within ten years of menopause, the benefits of hormone therapy generally outweigh the risks.
Candidacy
Who hormone therapy is usually considered for
Commonly appropriate when
- Perimenopausal or menopausal symptoms that interfere with sleep, work or relationships
- Under 60, or within about ten years of your final period
- Early, surgical or medical menopause
- Genitourinary symptoms such as dryness, discomfort or recurrent urinary irritation
- Elevated osteoporosis risk with low bone density
Requires caution or an alternative
- A personal history of breast or endometrial cancer
- Unexplained vaginal bleeding that has not been investigated
- A prior blood clot, stroke or heart attack
- Active liver disease
- Pregnancy, or the possibility of it
Associated symptoms
The symptoms most often attributed to it
Each symptom below has its own guide explaining what drives it and which hormones are usually involved.
- Hot flashesSudden heat, flushing, sweating
- Night sweatsWaking soaked and overheated
- Sleep issuesFalling asleep, staying asleep
- Brain fogWord-finding and memory lapses
- AnxietyNew or worsening, often at 3am
- Mood swingsShort fuse, sudden tears
- Low libidoDesire that quietly disappeared
- Vaginal drynessDiscomfort and painful intimacy
- Joint painMorning stiffness and aching
- FatigueTired no matter how you sleep
- Weight gainBelly changes despite no change in habits
- Hair thinningMore shedding, less density
Keep learning
Where to go deeper
- The hormones hub — every hormone, life stage and imbalance pattern in one place.
- BHRT vs. traditional HRT — how compounded bioidentical therapy differs from standardized prescriptions.
- Resources and guides — symptom trackers, workbooks and downloadable hormone guides from Dr. Tammy.
- Frequently asked questions — the questions women ask most about hormone care.
- The blog — new research, explained without the jargon.
Ready to look at care?
If you already understand the therapy and want to see how it's delivered — testing, formulation, coaching and follow-up — that's the program page.
Explore Hormone Replacement TherapyHRT FAQs
Hormone therapy questions
Straight answers about HRT, BHRT, safety and the research — no pressure, no jargon.
Hormone replacement therapy (HRT), also called menopausal hormone therapy, restores hormones — usually estrogen and progesterone, and sometimes testosterone — that decline through perimenopause and menopause. The aim is to bring levels back into a range where symptoms ease and where bone and tissue health are supported.
Bioidentical hormone replacement therapy uses hormones that are structurally identical to the ones the body makes, typically derived from plant sterols. Receptors respond to them the same way. Some bioidentical hormones — estradiol and micronized progesterone — are FDA-approved and widely prescribed; others are prepared by compounding pharmacies, which allows doses to be tailored beyond the standard strengths.
For most healthy women who begin within about ten years of menopause or before age 60, major medical societies agree the benefits generally outweigh the risks. Safety depends on your history, the hormones used, the route of delivery and how closely therapy is monitored — which is why it is individualized rather than standardized.
The 2002 Women's Health Initiative reported a small increase in breast cancer diagnoses in the combined estrogen-plus-progestin arm — fewer than one additional case per thousand women per year. The estrogen-only arm did not show an increase. Participants averaged 63 years of age and used oral conjugated equine estrogen with a synthetic progestin, so the findings do not transfer cleanly to a 50-year-old using transdermal estradiol with micronized progesterone.
Yes. Systemic estrogen without adequate progesterone increases the risk of endometrial hyperplasia and cancer. Progesterone is prescribed alongside estrogen for anyone with an intact uterus.
Transdermal estradiol avoids first-pass liver metabolism, and unlike oral estrogen it is not associated with an increased risk of venous clots. That makes the transdermal route the preferred option for many women, particularly those with clotting, migraine or metabolic considerations.
Hot flashes, night sweats and sleep often improve within two to four weeks. Libido, body composition, skin and hair typically change over three to six months as levels stabilize and dosing is refined.
There is no fixed stop date. Current guidance moved away from arbitrary time limits toward periodic review of symptoms, risks and goals — a conversation to revisit with your clinician, not a countdown.
Testing gives a baseline for estradiol, progesterone, testosterone, DHEA-S and thyroid, and is used alongside your symptoms and history rather than in place of them. In perimenopause especially, levels fluctuate day to day, so a symptom picture often carries more weight than any single number.
Where to go from here
Start by finding out whether your symptoms are hormonal
The assessment maps what you're experiencing to the hormones most likely behind it. If hormone therapy looks relevant, the program page explains how care at Hormone Bliss works.